156 related articles for article (PubMed ID: 34328113)
41. Review article: bugs, inflammation and mood-a microbiota-based approach to psychiatric symptoms in inflammatory bowel diseases.
Thomann AK; Mak JWY; Zhang JW; Wuestenberg T; Ebert MP; Sung JJY; Bernstein ÇN; Reindl W; Ng SC
Aliment Pharmacol Ther; 2020 Jul; 52(2):247-266. PubMed ID: 32525605
[TBL] [Abstract][Full Text] [Related]
42. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
[TBL] [Abstract][Full Text] [Related]
43. The Gut Microbiota in Collagenous Colitis Shares Characteristics With Inflammatory Bowel Disease-Associated Dysbiosis.
Carstens A; Dicksved J; Nelson R; Lindqvist M; Andreasson A; Bohr J; Tysk C; Talley NJ; Agréus L; Engstrand L; Halfvarson J
Clin Transl Gastroenterol; 2019 Jul; 10(7):e00065. PubMed ID: 31343467
[TBL] [Abstract][Full Text] [Related]
44. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
[TBL] [Abstract][Full Text] [Related]
45. The Microbiota and the Immune Response: What Is the Chicken and What Is the Egg?
Fritsch J; Abreu MT
Gastrointest Endosc Clin N Am; 2019 Jul; 29(3):381-393. PubMed ID: 31078242
[TBL] [Abstract][Full Text] [Related]
46. Premedication as primary prophylaxis does not influence the risk of acute infliximab infusion reactions in immune-mediated inflammatory diseases: A systematic review and meta-analysis.
Fumery M; Tilmant M; Yzet C; Brazier F; Loreau J; Turpin J; Le Mouel JP; Goeb V; Nguyen-Khac E; Singh S; Dupas JL; Diouf M
Dig Liver Dis; 2019 Apr; 51(4):484-488. PubMed ID: 30686715
[TBL] [Abstract][Full Text] [Related]
47. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease.
Scher JU; Ubeda C; Artacho A; Attur M; Isaac S; Reddy SM; Marmon S; Neimann A; Brusca S; Patel T; Manasson J; Pamer EG; Littman DR; Abramson SB
Arthritis Rheumatol; 2015 Jan; 67(1):128-39. PubMed ID: 25319745
[TBL] [Abstract][Full Text] [Related]
48. Sympathetic Nerve Hyperactivity in the Spleen: Causal for Nonpathogenic-Driven Chronic Immune-Mediated Inflammatory Diseases (IMIDs)?
Bellinger DL; Lorton D
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652832
[TBL] [Abstract][Full Text] [Related]
49. Effects of Bioactive Peptide on Inflammatory Bowel Disease, Focus on Signal Transduction and Intestinal Microbiota.
Ma Y; Yan W; Ding S; Fei Y; Liu G; Fang J
Curr Pharm Des; 2018; 24(24):2782-2788. PubMed ID: 30156150
[TBL] [Abstract][Full Text] [Related]
50. Parthenolide ameliorates colon inflammation through regulating Treg/Th17 balance in a gut microbiota-dependent manner.
Liu YJ; Tang B; Wang FC; Tang L; Lei YY; Luo Y; Huang SJ; Yang M; Wu LY; Wang W; Liu S; Yang SM; Zhao XY
Theranostics; 2020; 10(12):5225-5241. PubMed ID: 32373209
[TBL] [Abstract][Full Text] [Related]
51. The gut microbiota heterogeneity and assembly changes associated with the IBD.
Sun Y; Li L; Xia Y; Li W; Wang K; Wang L; Miao Y; Ma S
Sci Rep; 2019 Jan; 9(1):440. PubMed ID: 30679676
[TBL] [Abstract][Full Text] [Related]
52. Bile Acid-Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside.
Yang M; Gu Y; Li L; Liu T; Song X; Sun Y; Cao X; Wang B; Jiang K; Cao H
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579027
[TBL] [Abstract][Full Text] [Related]
53. Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease.
Schulberg J; De Cruz P
Intern Med J; 2016 Mar; 46(3):266-73. PubMed ID: 26968595
[TBL] [Abstract][Full Text] [Related]
54. Hepatic glycogen storage diseases are associated to microbial dysbiosis.
Colonetti K; Bento Dos Santos B; Nalin T; Moura de Souza CF; Triplett EW; Dobbler PT; Schwartz IVD; Roesch LFW
PLoS One; 2019; 14(4):e0214582. PubMed ID: 30939160
[TBL] [Abstract][Full Text] [Related]
55. The role of the gut microbiota in the treatment of inflammatory bowel diseases.
Aggeletopoulou I; Konstantakis C; Assimakopoulos SF; Triantos C
Microb Pathog; 2019 Dec; 137():103774. PubMed ID: 31586663
[TBL] [Abstract][Full Text] [Related]
56. Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches.
Alshehri D; Saadah O; Mosli M; Edris S; Alhindi R; Bahieldin A
Bosn J Basic Med Sci; 2021 Jun; 21(3):270-283. PubMed ID: 33052081
[TBL] [Abstract][Full Text] [Related]
57. Deciphering Gut Microbiota Dysbiosis and Corresponding Genetic and Metabolic Dysregulation in Psoriasis Patients Using Metagenomics Sequencing.
Xiao S; Zhang G; Jiang C; Liu X; Wang X; Li Y; Cheng M; Lv H; Xian F; Guo X; Tan Y
Front Cell Infect Microbiol; 2021; 11():605825. PubMed ID: 33869074
[TBL] [Abstract][Full Text] [Related]
58. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease.
Shaw KA; Bertha M; Hofmekler T; Chopra P; Vatanen T; Srivatsa A; Prince J; Kumar A; Sauer C; Zwick ME; Satten GA; Kostic AD; Mulle JG; Xavier RJ; Kugathasan S
Genome Med; 2016 Jul; 8(1):75. PubMed ID: 27412252
[TBL] [Abstract][Full Text] [Related]
59. Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease.
Sultan S; El-Mowafy M; Elgaml A; Ahmed TAE; Hassan H; Mottawea W
Front Physiol; 2021; 12():715506. PubMed ID: 34646151
[TBL] [Abstract][Full Text] [Related]
60. Altered composition and function of intestinal microbiota in autism spectrum disorders: a systematic review.
Liu F; Li J; Wu F; Zheng H; Peng Q; Zhou H
Transl Psychiatry; 2019 Jan; 9(1):43. PubMed ID: 30696816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
